PharmaBoardroom

Hospital Investments in Turkey: Bucking the Trend

Bucking a global trend for increased focus on outpatient and preventative care, Turkey is doubling down on hospital investment.…

Malaysia’s Unexpected Health Reform Program

After 61 years of single-party rule, the May 2018 electoral victory of the populist Pakatan Harapan (PH) coalition sent shockwaves through the…

Cannabinoid Drugs, Medicinal Cannabis and Opioid Drugs: Ecuador

An intro to the legal situation for medical cannabis, cannabinoid drugs and opioids in Ecuador. Prepared in association with Corral Rosales, a leading…

Jack Wang – Founder & CEO, Biomobie, China

Jack Wang, founder and CEO of Biomobie, shares the inspirational story behind the establishment of the company, the regenerative principle driving the…

Top 20 Pharma Companies in France (2018)

The Top 20 pharma companies in France, ranked by total turnover at ex-manufacturer prices for 2018. Swiss giant Novartis is in first place with a EUR…

Mexico’s Healthcare System: Perspectives from the Pharma…

Cristobal Thompson is the Executive Director at AMIIF (Asociacion Mexicana de Industrias de Investigacion Farmaceutica). The AMIIF represents more…

Armağan Vurdu – General Secretary, IMMIB, Turkey

Armağan Vurdu, general secretary of the Istanbul Minerals and Metals Exporters Association (IMMIB) highlights the strategic importance of the…

Adam Dunnett – Secretary General, EU Chamber of Commerce in…

Adam Dunnett, secretary general of the European Union Chamber of Commerce in China (European Chamber) outlines the organization’s three key roles of…

Year in Review – Transformational Transactions Dominated…

Christoph Bieri, PhD is Managing Partner of Kurmann Partners, an M&A firm advising Pharma and MedTech companies on strategic mid-market deals in…

Franck Hamalian – General Manager, Aspen France

Franck Hamalian, general manager of the French affiliate of Aspen, a specialty and branded multinational pharmaceutical company from South Africa,…

Egyptian Pharma Market Snapshot

The Egyptian pharma market grew at a compound annual growth rate (CAGR) of 17 percent between 2011 and 2017 to reach a total market valuation of EGP…

Andras Gizur – President China & APAC, Gedeon Richter

Andras Gizur, president China & APAC for Gedeon Richter, shares his insights on the current market environment in China following the spate of…

Tagged with M